EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Cash and Bank History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash and Bank | ₹165 Cr | ₹232 Cr | ₹458 Cr | ₹313 Cr | ₹524 Cr |
What is the latest Cash and Bank ratio of EMCURE PHARMACEUTICALS ?
| Year | Cash and Bank |
|---|---|
| Mar2025 | ₹165 Cr |
| Mar2024 | ₹232 Cr |
| Mar2023 | ₹458 Cr |
| Mar2022 | ₹313 Cr |
| Mar2021 | ₹524 Cr |
How is Cash and Bank of EMCURE PHARMACEUTICALS Trending?
| Years | Cash and Bank | % Change | |
|---|---|---|---|
| Mar2025 | ₹165 Cr | -28.88 | |
| Mar2024 | ₹232 Cr | -49.28 | |
| Mar2023 | ₹458 Cr | 46.27 | |
| Mar2022 | ₹313 Cr | -40.16 | |
| Mar2021 | ₹524 Cr | - | |
Compare Cash and Bank of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹28,742.4 Cr | 3.1% | -0.8% | 18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,615.0 Cr | 4% | -4.9% | -2.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,943.0 Cr | 1.1% | -9.3% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹133,336.0 Cr | -1.3% | -3.7% | 24% | Stock Analytics | |
| CIPLA | ₹107,499.0 Cr | 1.5% | -9.3% | -7.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,590.0 Cr | 5% | -0.1% | 3.3% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 3.1% |
-0.8% |
18.8% |
| SENSEX | 3.5% |
-1.7% |
7.8% |
You may also like the below Video Courses